Search by Drug Name or NDC
NDC 27241-0115-05 Divalproex sodium 125 mg/1 Details
Divalproex sodium 125 mg/1
Divalproex sodium is a ORAL CAPSULE, COATED PELLETS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ajanta Pharma USA Inc.. The primary component is DIVALPROEX SODIUM.
MedlinePlus Drug Summary
Valproic acid is used alone or with other medications to treat certain types of seizures. Valproic acid is also used to treat mania (episodes of frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). It is also used to prevent migraine headaches but not to relieve headaches that have already begun. Valproic acid is in a class of medications called anticonvulsants. It works by increasing the amount of a certain natural substance in the brain.
Related Packages: 27241-0115-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Valproic Acid
Product Information
| NDC | 27241-0115 |
|---|---|
| Product ID | 27241-115_73b581e8-606f-4264-8358-d3dd657d2325 |
| Associated GPIs | 7250001010H120 |
| GCN Sequence Number | 004537 |
| GCN Sequence Number Description | divalproex sodium CAP DR SPR 125 MG ORAL |
| HIC3 | H4B |
| HIC3 Description | ANTICONVULSANTS |
| GCN | 17400 |
| HICL Sequence Number | 001884 |
| HICL Sequence Number Description | DIVALPROEX SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Divalproex sodium |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Divalproex sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, COATED PELLETS |
| Route | ORAL |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIVALPROEX SODIUM |
| Labeler Name | Ajanta Pharma USA Inc. |
| Pharmaceutical Class | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213181 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 27241-0115-05 (27241011505)
| NDC Package Code | 27241-115-05 |
|---|---|
| Billing NDC | 27241011505 |
| Package | 500 CAPSULE, COATED PELLETS in 1 BOTTLE (27241-115-05) |
| Marketing Start Date | 2020-05-15 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.27424 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | DIVALPROEX DR 125 MG CAP SPRNK |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |